MDGL
NASDAQ · Biotechnology
Madrigal Pharmaceuticals Inc
$510.04
-0.32 (-0.06%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
+6.52%
1Y
+45.93%
YTD
-14.12%
Open$511.97
Previous Close$510.36
Day High$517.32
Day Low$502.79
52W High$615.00
52W Low$331.00
Volume—
Avg Volume482.7K
Market Cap11.78B
P/E Ratio—
EPS$-12.87
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$526.21
Below
SMA 200
$421.32
Above
RSI (14)
32.6
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
24 analysts
Price Target
-76.5% upside
Current
$510.04
$510.04
Target
$119.83
$119.83
$78.20
$119.83 avg
$127.79
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 987.02M | 3.52B | 3.21B |
| Net Income | -296,890,343 | -1,086,916,353 | -1,008,552,409 |
| Profit Margin | -30.1% | -30.9% | -31.4% |
| EBITDA | -310,366,981 | -994,214,061 | -913,486,769 |
| Free Cash Flow | — | -874,407,524 | -958,278,915 |
| Rev Growth | — | +9.6% | -7.9% |
| Debt/Equity | 0.56 | 0.46 | 0.46 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $246.04 | +0.89% | 118.6 | 430.95B |
| AMGN | Amgen Inc | $410.95 | +1.51% | 25.1 | 219.39B |
| GILD | Gilead Sciences Inc | $133.21 | +1.80% | — | 165.85B |
| VRTX | Vertex Pharmaceuticals Inc | $496.07 | +2.49% | 28.3 | 124.51B |
| REGN | Regeneron Pharmaceuticals | $784.36 | +1.59% | 18.4 | 79.53B |
| ALNY | Alnylam Pharmaceuticals Inc | $219.20 | +1.43% | 35.2 | 28.41B |